Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: Relationship with von Willebrand factor

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 3, 1997, Pages 200-204

  Blann, A D ^a   Goode, G K ^b   Miller, J P ^c   McCollum, C N ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

atherosclerosis; hypercholesterolaemia; Soluble P selectin; von Willebrand factor

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; SMOKING; THROMBOSIS;

EID: 0030915641     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199704000-00008     Document Type: Article

References (29)

1. Steinberg D. The cholesterol controversy is over. Why did it take so long? Circulation 1984; 80: 1070-1078.
2. Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci 1993; 50: 221-234.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
4. Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemostas 1993; 70: 105-110.
5. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Int Med 1996; 239: 17-34.
6. Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128: 135-138.
7. Blann AD, Lip GYH, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997: In press.
8. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1977: In press.
9. Jilma B, Fasching P, Ruthner C, et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemostas 1996; 76: 328-332.
10. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive disorders. Blood 1994; 83: 1535-1541.
11. Blann AD, Seigneur M, Boisseau MR, Taberner DA, McCollum CN. Soluble P-selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coag Fibrinol 1996; 7: 789-793.
12. Blann AD, McCollum CN. Increased levels of plasma P-selectin - a new marker for the progression of atherosclerosis. Br J Haem 1996; 93 (Suppl 1): 25 (abstract).
13. Boneu B, Abbal M, Plante J, Bierme R. Factor VIII complex and endothelial cell damage. Lancet 1975; i: 1430.
14. Blann AD. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993; 50: 125-134.
15. Blann AD, Davies A, Miller JP, McCollum CN. von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease. Am J Haem: In press.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Altman DG. How large a sample? In: Gore SM, Altman DG, eds. Statistics in Practice. London: British Medical Association, 1982; 6-8.
18. D'Souza D, Wu KK, Hellums JD, Phillips MD. Platelet activation and arterial thombosis. Lancet 1994; 344: 991-995.
19. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430-1432.
20. Lip GYH, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens 1995; 13: 1674-1678.
21. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemostas 1993; 70: 111-118.
22. Jilma B, Eichler HG, Vondrovec B, et al. Effects of desmopressin on circulating P-selectin. Br J Haem 1996; 93: 432-436.
23. Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of the human gene encoding granule membrane protein 140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem 1990; 265: 21381-21385.
24. Takeda I, Kaise S, Nishimaki T, Kasukawa R. Soluble P-selectin in the plasma of patients with connective tissue diseases. Int Arch Allergy Immunol 1994; 105: 128-134.
25. Katayama M, Handa M, Araki Y, et al. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haem 1993; 84: 702-710.
26. Schadendorf D, Diehl S, Zuberbier T, Schadendorf C, Henz BM. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlate with clinical stage. Dermatology 1996; 192: 89-93.
27. Bruserud O, Akselen PE, Bergheim J, Nesthus I. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy induced leucopenia and bacterial infections. Br J Haem 1995; 91: 394-402.
28. Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140. Science 1990; 249: 414-417.
29. Ikeda H, Nakayama H, Oda T, et al. Soluble form of P-selectin in patients with acute myocardial infarction. Coronary Artery Dis 1994; 5: 515-518.